Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro can cause diarrhoea. It is one of the most commonly reported gastrointestinal side effects of tirzepatide, particularly in the early weeks of treatment or after a dose increase. Most people find it settles as the body adjusts, but knowing what to expect — and when to seek help — makes the experience far easier to manage. As a prescription-only medicine, Mounjaro is always started and adjusted under clinical supervision; a prescriber assesses your full health picture before treatment begins. You can read more about the broader side-effect profile on our Mounjaro side effects overview.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two gut-hormone receptors, GIP and GLP-1, which together slow the movement of food through your digestive system and change how your gut handles fluid and bile. For many people, that adjustment is felt most in the lower gut as looser stools or diarrhoea, particularly in the first few weeks of treatment. The same mechanism explains why constipation is also on the side-effect list, the gut is recalibrating, and different people land in different places.
Clinical trial data support this: gastrointestinal effects were among the most commonly reported events in the SURMOUNT-1 programme. The NHS tirzepatide medicines page lists diarrhoea as a common side effect, meaning it affects somewhere between one in ten and one in one hundred people taking the medicine. That range is worth keeping in mind, common does not mean certain.
The pattern matters more than the raw fact that it can happen. Diarrhoea that starts within a day or two of a dose increase, then gradually eases over a week or two, is behaving exactly as expected. Diarrhoea that arrives out of nowhere weeks into a stable dose, or that is severe and continuous, sits in different territory and deserves a different response. Our page on managing diarrhoea on Mounjaro covers the practical day-to-day side in more detail.
The real question most people face is not whether diarrhoea can happen (it clearly can) but what to do when it does. There are broadly three positions. First, mild and short-lived symptoms that are inconvenient but not limiting; these typically do not require any change in treatment, just practical management. Second, symptoms that are disruptive enough to affect daily life or that are not settling after two to three weeks; these are worth raising with your prescriber, who may consider a slower titration schedule. Third, severe or dehydrating symptoms; these require prompt action regardless of where you are in the dose schedule.
Hydration is the thread running through all three positions. Diarrhoea causes fluid and electrolyte loss, and on a medicine that also reduces appetite and overall food intake, it is easy to under-drink without realising it. Plain water, diluted fluids, and foods with high water content all help. Fatty or very high-fibre meals can worsen GI symptoms on tirzepatide, a lighter, lower-fat diet while your body adjusts is practical rather than punishing.
If you are mid-titration and wondering whether to move up to the next dose while diarrhoea is still ongoing, that decision belongs with your prescriber. At nume, a named clinician reviews your situation before any dose change; you can raise exactly this kind of question through our aftercare team. For a fuller picture of what to expect across the dose schedule, our Mounjaro treatment page is a good starting point, or you can explore all available treatment options with our prescribers.
Most diarrhoea on Mounjaro is uncomfortable but not dangerous. Some presentations, though, need medical attention without delay.
Get help the same day (or call 999 if severe) if you experience any of the following: severe stomach pain that spreads to your back (with or without vomiting), which can be a sign of acute pancreatitis; signs of significant dehydration including dizziness, a dry mouth, very dark urine, or passing no urine for several hours; blood in your stools; or diarrhoea that is continuous and shows no sign of easing after 24 hours despite rest and fluids.
The MHRA highlighted acute pancreatitis as a known but infrequent serious risk for GLP-1 medicines in a Drug Safety Update published in January 2026. Severe abdominal pain on tirzepatide is not something to wait out. The MHRA's Yellow Card scheme lets patients report any suspected side effect directly (including diarrhoea you feel is not adequately addressed) and that reporting data genuinely helps regulators understand real-world experiences with newer medicines like Mounjaro.
For symptoms that are persistent but not emergency-level, your first call should be your prescriber or GP rather than a search engine. If you are on treatment through nume and are uncertain, our aftercare team is available seven days a week. Questions about sickness and diarrhoea occurring together are also covered on our page about sickness and diarrhoea on Mounjaro. If you find diarrhoea to be your dominant symptom rather than nausea, it is worth reading about how diarrhoea presents differently for different people on this treatment.
One thing our prescribers hear regularly is that people were warned about nausea but not diarrhoea, so when loose stools appear (sometimes during a busy week, sometimes on a bank holiday when the GP is closed) it feels more alarming than it needs to. It is worth knowing this going in.
Mounjaro is a prescription medicine, not an over-the-counter supplement, and the clinical review that comes with a legitimate prescription is part of what makes it safer to use. At nume, your prescriber discusses common side effects as part of the consultation, not as small print, but as practical preparation. If you are considering treatment and want to understand the full picture before deciding, speaking to our prescribers is the right next step. You can also read about how diarrhoea specifically is managed, and what tends to help, on our guide to reducing diarrhoea on Mounjaro.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.